High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer.
about
CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progressionScavenger Receptors: Emerging Roles in Cancer Biology and ImmunologyChemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic AgentsCXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targetingChemokines and chemokine receptors: update on utility and challenges for the clinician.A multi-targeted approach to suppress tumor-promoting inflammationChemokine CXCL16 expression suppresses migration and invasiveness and induces apoptosis in breast cancer cells.Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis.The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers.Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors.Up-regulation of the pro-inflammatory chemokine CXCL16 is a common response of tumor cells to ionizing radiationThe emerging role of CXC chemokines and their receptors in cancer.Noninvasive detection of inflammation-associated colon cancer in a mouse modelCombinations of immunotherapy and radiation in cancer therapy.CXCL16 suppresses liver metastasis of colorectal cancer by promoting TNF-α-induced apoptosis by tumor-associated macrophages.Enhancement of T cell recruitment and infiltration into tumours.CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitroImage analyzer-based assessment of tumor-infiltrating T cell subsets and their prognostic values in colorectal carcinomas.Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival.Expression analysis and clinical significance of CXCL16/CXCR6 in patients with bladder cancer.CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clusteringRadiation-induced CXCL16 release by breast cancer cells attracts effector T cells.CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor controlDefinitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer.Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancerVascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-κB pathways induced by paracrine cytokines.Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies.CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoproteinLymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotypeInternational Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.Genetic diversity of the KIR/HLA system and outcome of patients with metastatic colorectal cancer treated with chemotherapy.Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity.Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer.Immune mediators as potential diagnostic tools for colorectal cancer: from experimental rationale to early clinical evidence.Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment.Antitumor immune activity by chemokine CX3CL1 in an orthotopic implantation of lung cancer model in vivo.Blockade of CXCR6 reduces invasive potential of gastric cancer cells through inhibition of AKT signaling.Blockade of the CXCR6 signaling inhibits growth and invasion of hepatocellular carcinoma cells through inhibition of the VEGF expression.Escin suppresses migration and invasion involving the alteration of CXCL16/CXCR6 axis in human gastric adenocarcinoma AGS cells.Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
P2860
Q24635943-A56CB168-1490-449A-9261-57D6CE5D5BB5Q26799114-675741E9-C5F1-4866-85A7-D098BD8E45E8Q26830743-56E618C6-B929-4FBF-A0DA-E63DE1F09A6BQ26849606-0486E019-7C2C-46CA-8C91-A2398EB4D7BFQ27687402-929C6A3E-923E-4F28-A71C-BD28115FE8DDQ28393278-D6E066B8-D9A3-44C4-8122-588E759D0D91Q30412948-2395DB6E-5165-4158-AD23-32B72012A294Q30432069-288A42EF-D05C-4F0B-8224-8D47774A0ED3Q30438926-9ADD58E0-E0E2-4BE2-85E6-F8DCCCF5CF9FQ30505678-02C0CDD0-1A8D-4283-B16A-56DCA9C5D191Q33802647-48987E41-817E-41F3-8946-060A6AC7A210Q34263645-32813D78-9EDD-41DA-9977-16D2F3925B52Q34411737-DE5E38E9-7EEA-4E8B-BB56-8B6FE9FAB6FBQ34582640-C1FFCB35-0192-46AE-BD78-C2639DC65E83Q34990965-E997ACD0-998C-46B9-81E1-F1D8C65E0BE2Q35178939-A6A2CE5C-AD83-4828-9E01-6FFAC14AB977Q35181573-C2C6CFD8-4152-430B-9A95-AF4C9C6B56DDQ35433402-0027BA81-962E-4905-AE7E-4DAB4B0C5E61Q35645484-8C957B84-EDD1-4CB7-A215-5D68AE50D919Q36475434-3B1A7346-C2A3-49B4-BD2E-0B410D6B7335Q36916482-E7D25403-1F69-41C9-B386-91D77DE4FD3EQ36983211-3131356A-0FBC-4CDB-8F89-A1EC0698B9C8Q37079121-EE4802B3-368A-4723-9D9E-97B40D750AE6Q37100703-862F9F21-E110-4E4A-A476-AF1B527FBEB7Q37111136-1C775407-709B-4E37-A54E-D84F5D51CA67Q37115310-C83F3527-F481-4E9F-94D4-A8C7EC0AB8AFQ37134430-06339A03-A730-4EE7-8DC9-F8BE5A2903A9Q37197326-6E3D9B81-ABB7-41BC-8C9B-70899AB32D77Q37407802-26226CB0-8901-46F2-9E87-C40CC72FB99AQ37432097-CEE457B0-76BB-4926-9A6D-3DDF013D9D8AQ37537926-612878CB-3F79-431D-B1A9-88F46D60ACC5Q37650715-908448D9-81B3-4455-BB7B-300C68B78F6DQ37689104-320D7D16-4447-47CC-B82E-C41DE4B06AC9Q38197678-B58F7A65-8B30-4EEB-9F3A-6A72D974D8E9Q38223355-DC2606AE-AE0F-4A55-9807-4E8E3FFC98FDQ38292325-BA0E3112-12E0-4EC3-B0AF-600FA405E2FFQ38881161-B5223963-5829-45BD-897A-4C147F06C691Q38921923-14507180-C422-476D-94EF-0467BECA4356Q38986743-9053BBF9-3902-41DC-B846-041818F938C9Q39489655-BA3C5A76-CB49-42D7-9EE7-C21570EB3DE7
P2860
High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
High-level expression of chemo ...... phocytes in colorectal cancer.
@en
type
label
High-level expression of chemo ...... phocytes in colorectal cancer.
@en
prefLabel
High-level expression of chemo ...... phocytes in colorectal cancer.
@en
P2093
P1433
P1476
High-level expression of chemo ...... phocytes in colorectal cancer.
@en
P2093
Ikuo Saiki
Isaya Hashimoto
Kanna Shinohara
Kazuhiro Tsukada
Keiichi Koizumi
Koichi Tsuneyama
Osamu Yoshie
Shozo Hojo
Takashi Nakayama
Takayuki Minami
P304
P356
10.1158/0008-5472.CAN-06-3424
P407
P577
2007-05-01T00:00:00Z